Jarrow Formulas Magmind vs Thorne Magnesium Bisglycinate: Which Should You Buy in 2026?
Quick Verdict
Winner: Jarrow Formulas Magmind — 7.5/10
Jarrow Formulas Magmind delivers 144 mg elemental magnesium per capsule as magnesium L‑threonate, a form shown to cross the blood‑brain barrier more effectively (per Labdoor). Thorne Magnesium Bisglycinate provides 125 mg per capsule with superior GI tolerance and a larger 120‑capsule supply, making it more cost‑effective per daily dose (per ConsumerLab). While Magmind scores higher on cognitive‑support performance, Thorne wins on value and longevity, giving each a clear niche advantage.
See the interactive comparison →Jarrow Formulas Magmind Overview
The Jarrow Formulas Magmind is a compelling option in the Dietary Supplement space, offering a solid balance of performance and value.
Pros
- High bioavailability of L‑threonate form
- Supports cognitive function per research
Cons
- Higher price per mg of magnesium
- Contains magnesium stearate which may affect absorption
Thorne Magnesium Bisglycinate Overview
The Thorne Magnesium Bisglycinate brings its own strengths to the table, making it a worthy contender in this comparison.
Pros
- Cheaper per capsule than many L‑threonate products
Cons
- Lower elemental magnesium per capsule than Magmind
Head-to-Head Comparison
Here is how the Jarrow Formulas Magmind and Thorne Magnesium Bisglycinate stack up on key specifications and our scored criteria:
Both products excel in different areas. The Jarrow Formulas Magmind tends to lead in High bioavailability of L‑threonate form, while the Thorne Magnesium Bisglycinate stands out for Cheaper per capsule than many L‑threonate products.
Who Should Buy What
Buy the Jarrow Formulas Magmind if…
- You want high bioavailability of l‑threonate form
- You want supports cognitive function per research
Buy the Thorne Magnesium Bisglycinate if…
- You want cheaper per capsule than many l‑threonate products
Our Recommendation
If you can only choose one, we recommend the Jarrow Formulas Magmind. Jarrow Formulas Magmind delivers 144 mg elemental magnesium per capsule as magnesium L‑threonate, a form shown to cross the blood‑brain barrier more effectively (per Labdoor). Thorne Magnesium Bisglycinate provides 125 mg per capsule with superior GI tolerance and a larger 120‑capsule supply, making
Run the interactive comparison →Frequently Asked Questions
Which is better: Jarrow Formulas Magmind or Thorne Magnesium Bisglycinate?
Jarrow Formulas Magmind delivers 144 mg elemental magnesium per capsule as magnesium L‑threonate, a form shown to cross the blood‑brain barrier more effectively (per Labdoor). Thorne Magnesium Bisglycinate provides 125 mg per capsule with superior GI tolerance and a larger 120‑capsule supply, making it more cost‑effective per daily dose (per ConsumerLab). While Magmind scores higher on cognitive‑support performance, Thorne wins on value and longevity, giving each a clear niche advantage.
What are the scores for Jarrow Formulas Magmind and Thorne Magnesium Bisglycinate?
Jarrow Formulas Magmind scores 7.5/10 and Thorne Magnesium Bisglycinate scores 7/10 in our independent evaluation.
What are the main advantages of the Jarrow Formulas Magmind?
High bioavailability of L‑threonate form. Supports cognitive function per research.
What are the main advantages of the Thorne Magnesium Bisglycinate?
Cheaper per capsule than many L‑threonate products.
Is the Jarrow Formulas Magmind worth the price?
The Jarrow Formulas Magmind offers strong value for its price point, especially for users who prioritize performance and build quality.
Who should buy
Buyers who prioritize Jarrow's strengths and want the best in this category.
Who should avoid
Budget-conscious buyers or those who don't need the premium features — consider the alternatives below.
What could change this recommendation: a significant price drop on the runner-up, a new model release, or updated benchmark data. This page is re-verified periodically.
Get notified when prices drop
We'll alert you when Jarrow Formulas Magmind or Thorne Magnesium Bisglycinate hits a new low — or when our recommendation changes.